Furthermore, although heterogenous subpopulations have been connected to prostate cancer (PCa) progression and AR therapy resistance19–24, the key survival factor of lineage-plastic and stem-like cells has yet to be defined. The gene discussed is AR; the disease is Familial prostate cancer.